Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. National Comprehensive Cancer Network. Breast Cancer (Version 2.2022). https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 26 Mar 2022.

  2. Boughey JC, McCall LM, Ballman KV, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg. 2014;260:608–16.

    Article  Google Scholar 

  3. Angarita S, Ye L, Rünger D, et al. Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes: hope for more limited axillary surgery. Ann Surg Oncol. 2021;28(5):2609–18. https://doi.org/10.1245/s10434-020-09228-5.

    Article  PubMed  Google Scholar 

  4. Orozco JIJ, Knijnenburg TA, Manughian-Peter AO. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018;9(1):4627. https://doi.org/10.1038/s41467-018-06715-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ensenyat-Mendez M, Rünger D, Orozco JIJ, et al. Epigenetic signatures predict pathologic nodal stage in breast cancer patients with estrogen receptor-positive, clinically node-positive disease. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11684-0.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Duke University School of Medicine, Durham, NC, USA

    Maggie L. DiNome MD

  2. Cancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d’Investigació Sanitària Illes Balears (IdISBa), Palma, Spain

    Diego M. Marzese PhD

Authors
  1. Maggie L. DiNome MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diego M. Marzese PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maggie L. DiNome MD.

Ethics declarations

Disclosures

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

DiNome, M.L., Marzese, D.M. ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla. Ann Surg Oncol 29, 4725–4726 (2022). https://doi.org/10.1245/s10434-022-11767-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11767-y

Search

Navigation